SCHEMBL30847404

SCHEMBL30847404

Cc1nc2ccc(Br)cc2n1-c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.65
HTT P42858 1/20 0.65
ALDH1A1 P00352 2/20 0.55
HSD17B10 Q99714 2/20 0.51
CYP1A2 P05177 1/20 0.50
PDE10A Q9Y233 1/20 0.50
KDM4E B2RXH2 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPC1 O15118 1/20 0.47
DCTPP1 Q9H773 1/20 0.47
HCAR1 Q9BXC0 2/20 0.47
MAPT P10636 1/20 0.43
ATM Q13315 1/20 0.43
GALR3 O60755 1/20 0.43
NR2F2 P24468 1/20 0.43
LMNA P02545 1/20 0.42
GRM1 Q13255 1/20 0.42
TSHR P16473 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27112980 1.00 MAPK1 (0.65) MAPK1HTTALDH1A1HSD17B10CYP1A2
SCHEMBL338139 0.87 ALDH1A1 (0.68) MAPK1HTTALDH1A1HSD17B10PDE10A
SCHEMBL31144716 0.84 ALDH1A1 (0.52) MAPK1HTTALDH1A1HSD17B10CYP1A2
SCHEMBL1104809 0.83 HTT (0.69) MAPK1HTTALDH1A1HSD17B10CYP1A2
SCHEMBL10818841 0.83 PDE10A (0.54) MAPK1HTTALDH1A1CYP1A2PDE10A
SCHEMBL13916684 0.83 HTT (0.72) MAPK1HTTALDH1A1HSD17B10CYP1A2
SCHEMBL18314223 0.83 ESR1 (0.54) MAPK1HTTHSD17B10CYP1A2KDM4E
SCHEMBL13916683 0.81 HTT (0.70) MAPK1HTTALDH1A1HSD17B10CYP1A2
SCHEMBL1104832 0.81 MAPK1 (0.65) MAPK1HTTALDH1A1HSD17B10CYP1A2
SCHEMBL14247592 0.81 HCAR1 (0.47) MAPK1HTTALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044757-A1 AMINOPYRIMIDINE AND AMINOTRIAZINE DERIVATIVES AS MYC PROTEIN MODULATORS Sanford Burnham Prebys Medical Discovery Institute (US) 2024-02-29 WO disclosed